You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Biodegradable Vascular Coupling Device for End-to-End Anastomosis
SBC: Microsurgical Innovations Inc Topic: NHLBIProject Summary The objective of this Phase I SBIR proposal is to demonstrate the feasibility of a device designed to connect two small vessels together simply and easily and that would replace the hand suturing technique currently used to connect vessels in microsurgery and macrovascular end to end vascular repair surgeries This completely biodegradable vascular coupling device VCD being devel ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Biodegradable Vascular Coupling Device for End-to-End Anastomosis
SBC: Microsurgical Innovations Inc Topic: NHLBIProject Summary The objective of Microsurgical InnovationsMSIin this proposal is to develop a biodegradable vascular coupling deviceVCDwhich would replace the hand suturing technique currently used to connect arteries and veins in microvascular and macrovascular end to end vascular repair surgeriesOur device works for both arteries and veins and can rapidly connect the two vessel ends together in ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Accessible And Robust Tools for Glycosaminoglycan Profiling
SBC: ECHELON BIOSCIENCES, INC. Topic: 300Glycosaminoglycans (GAGs) are polysaccharides composed of a repeated disaccharide subunit and known to be important for the maintenance of structure and mechanical properties of the extracellular matrix. More recently, changes in the content, size, and composition of GAGs have been found to play biological roles in disease processes as well. For example, chondroitin sulfate (CS) is the most abunda ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
AccuTemp Sensor: Radiometry based non-invasive continuous core body temperature m
SBC: THERMIMAGE, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Accurate measurement of core body temperature during surgery as well as in critical care is imperative to a positive outcome and ongoing quality of life for patients. Core temperature management of patients during extended anesthesia such as cardio-pulmonary bypass (CPB) surgery is equally important, yet there is no accurate core body measurement device availab ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
AccuTemp Sensor: Radiometry based non-invasive continuous core body temperature monitoring for patients undergoing prolonged anesthesia and critically ill patients.
SBC: THERMIMAGE, INC. Topic: 300DESCRIPTION provided by applicant There is a growing need for accurate and continuous non invasive monitoring of brain temperature in hospitals and clinics throughout the world The need for physicians and anesthesiologists to know the brain as well as the core body temperature of a patient is well established Temperature management of patients under anesthesia during cardio pulmonary bypass s ...
SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
A fluorescent reporter detecting precise homologous recombination transgenesis activity
SBC: KDT, LLC Topic: NICHDThe broad long term objective and specific aims of the fast track SBIR research are to create a reagent RecombiRED for use in microinjection of embryos for identifying a subset of embryos as recombination competent injections The ability to quickly identify genome editing events in an embryo allows researcher to quickly make precision animal models of human disease states Precise animal m ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A fluorescent reporter detecting precise homologous recombination transgenesis activity
SBC: KDT, LLC Topic: NICHDThe broadlong term objective and specific aims of the fast track SBIR research are to create areagentRecombiREDfor use in microinjection of embryos for identifying a subset of embryosas recombination competent injectionsThe ability to quickly identify genome editing events inan embryo allows researcher to quickly make precision animal models of human disease statesPrecise animal models allow for g ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Aging Resistant Ceramics for Total Hip Arthroplasty
SBC: SINTX TECHNOLOGIES, INC. Topic: N/ADESCRIPTION (provided by applicant): Zirconia bio-ceramics (e.g. Prozyr) have the highest toughness and strength compared to other bio-ceramics such as alumina (e.g. Biolox) or zirconia-toughened alumina (Biolox-Delta). However, as highlighted by the recent recall of St. Gobain zirconia heads, a critical need remains to develop bio-ceramics with both significantly reduced wear characteristics and ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
ALTERNATIVE TO HEPARIN ANTICOAGULATION
SBC: Thrombodyne Inc Topic: N/ADESCRIPTION (provided by applicant): Anticoagulation of blood is necessary for prevention of clotting and/or thromboembolism during cardiopulmonary bypass or other procedures that require extracorporeal circulation. Conventionally, anticoagulation is achieved by administering heparin and reversed by neutralizing heparin with protamine. Both of these procedures may have potential pathological conse ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
ALTERNATIVE TO HEPARIN ANTICOAGULATION
SBC: Thrombodyne Inc Topic: N/ADESCRIPTION (provided by applicant): Anticoagulation of blood is necessary for prevention of clotting and/or thromboembolism during cardiopulmonary bypass or other procedures that require extracorporeal circulation. Conventionally, anticoagulation is achieved by administering heparin and reversed by neutralizing heparin with protamine. Both of these procedures may have potential pathological conse ...
SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health